Quick Answer
Beta Bionics, Inc. reported Total Assets of $328.74 million for fiscal year 2025.
Beta Bionics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $328.74M | +119.7% |
| 2024 | $149.65M | +36.0% |
| 2023 | $110.04M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $330.05M | — | +0.0% |
| June 30, 2025 | $329.97M | — | -2.4% |
| March 31, 2025 | $338.02M | — | +125.9% |
| December 31, 2024 | $149.65M | — | — |
- Beta Bionics, Inc. showed an increase of +119.7% in Total Assets compared to the prior fiscal year.
- Over the 2023–2025 period, Beta Bionics, Inc.’s total assets has grown by 198.7% (from $110.04 million to $328.74 million).
- The most recent figure is from Beta Bionics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: